Charles Schwab’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73M | Buy |
749,015
+126,101
| +20% | +$459K | ﹤0.01% | 2577 |
|
|
2025
Q1 | $1.2M | Buy |
622,914
+36,204
| +6% | +$69.5K | ﹤0.01% | 2782 |
|
|
2024
Q4 | $1.11M | Buy |
586,710
+18,043
| +3% | +$34.3K | ﹤0.01% | 2880 |
|
|
2024
Q3 | $751K | Sell |
568,667
-2,307
| -0.4% | -$3.05K | ﹤0.01% | 3011 |
|
|
2024
Q2 | $582K | Buy |
570,974
+491,170
| +615% | +$501K | ﹤0.01% | 3130 |
|
|
2024
Q1 | $146K | Hold |
79,804
| – | – | ﹤0.01% | 3269 |
|
|
2023
Q4 | $99K | Hold |
79,804
| – | – | ﹤0.01% | 3347 |
|
|
2023
Q3 | $91K | Hold |
79,804
| – | – | ﹤0.01% | 3363 |
|
|
2023
Q2 | $73K | Hold |
79,804
| – | – | ﹤0.01% | 3373 |
|
|
2023
Q1 | $44.7K | Sell |
79,804
-52,566
| -40% | -$29.5K | ﹤0.01% | 3365 |
|
|
2022
Q4 | $76.4K | Hold |
132,370
| – | – | ﹤0.01% | 3292 |
|
|
2022
Q3 | $42K | Buy |
+132,370
| New | +$42K | ﹤0.01% | 3367 |
|
|
2022
Q2 | – | Sell |
-476,974
| Closed | -$343K | – | 3541 |
|
|
2022
Q1 | $343K | Buy |
476,974
+33,016
| +7% | +$23.7K | ﹤0.01% | 3181 |
|
|
2021
Q4 | $1M | Hold |
443,958
| – | – | ﹤0.01% | 2907 |
|
|
2021
Q3 | $1.28M | Sell |
443,958
-658,251
| -60% | -$1.9M | ﹤0.01% | 2791 |
|
|
2021
Q2 | $4.18M | Buy |
1,102,209
+87,275
| +9% | +$331K | ﹤0.01% | 2434 |
|
|
2021
Q1 | $3.44M | Buy |
1,014,934
+58,925
| +6% | +$199K | ﹤0.01% | 2471 |
|
|
2020
Q4 | $2.68M | Buy |
956,009
+13,633
| +1% | +$38.2K | ﹤0.01% | 2513 |
|
|
2020
Q3 | $2.37M | Sell |
942,376
-104,548
| -10% | -$262K | ﹤0.01% | 2435 |
|
|
2020
Q2 | $14.2M | Buy |
1,046,924
+304,312
| +41% | +$4.13M | 0.01% | 1407 |
|
|
2020
Q1 | $5.63M | Buy |
742,612
+13,991
| +2% | +$106K | ﹤0.01% | 1775 |
|
|
2019
Q4 | $4.61M | Buy |
728,621
+26,565
| +4% | +$168K | ﹤0.01% | 2057 |
|
|
2019
Q3 | $2.75M | Buy |
702,056
+53,303
| +8% | +$209K | ﹤0.01% | 2267 |
|
|
2019
Q2 | $3.14M | Buy |
648,753
+81,813
| +14% | +$396K | ﹤0.01% | 2185 |
|
|
2019
Q1 | $4.64M | Buy |
566,940
+6,680
| +1% | +$54.7K | ﹤0.01% | 2008 |
|
|
2018
Q4 | $3.1M | Buy |
560,260
+210,638
| +60% | +$1.17M | ﹤0.01% | 2151 |
|
|
2018
Q3 | $3.09M | Sell |
349,622
-32,890
| -9% | -$290K | ﹤0.01% | 2266 |
|
|
2018
Q2 | $3.82M | Buy |
382,512
+36,391
| +11% | +$363K | ﹤0.01% | 2135 |
|
|
2018
Q1 | $3.3M | Buy |
346,121
+49,990
| +17% | +$476K | ﹤0.01% | 2138 |
|
|
2017
Q4 | $4.4M | Buy |
296,131
+57,798
| +24% | +$860K | ﹤0.01% | 1981 |
|
|
2017
Q3 | $4.69M | Buy |
238,333
+31,857
| +15% | +$627K | ﹤0.01% | 1904 |
|
|
2017
Q2 | $2.97M | Buy |
206,476
+81,346
| +65% | +$1.17M | ﹤0.01% | 2079 |
|
|
2017
Q1 | $1.15M | Buy |
125,130
+7,353
| +6% | +$67.7K | ﹤0.01% | 2381 |
|
|
2016
Q4 | $1.23M | Buy |
117,777
+6,622
| +6% | +$69K | ﹤0.01% | 2361 |
|
|
2016
Q3 | $1.01M | Buy |
111,155
+5,722
| +5% | +$51.8K | ﹤0.01% | 2409 |
|
|
2016
Q2 | $789K | Buy |
105,433
+1,764
| +2% | +$13.2K | ﹤0.01% | 2422 |
|
|
2016
Q1 | $935K | Buy |
103,669
+39,857
| +62% | +$359K | ﹤0.01% | 2371 |
|
|
2015
Q4 | $825K | Buy |
63,812
+1,625
| +3% | +$21K | ﹤0.01% | 2451 |
|
|
2015
Q3 | $601K | Buy |
62,187
+17,507
| +39% | +$169K | ﹤0.01% | 2551 |
|
|
2015
Q2 | $460K | Buy |
44,680
+23,785
| +114% | +$245K | ﹤0.01% | 2698 |
|
|
2015
Q1 | $233K | Buy |
20,895
+9,395
| +82% | +$105K | ﹤0.01% | 2915 |
|
|
2014
Q4 | $134K | Sell |
11,500
-5,419
| -32% | -$63.1K | ﹤0.01% | 3033 |
|
|
2014
Q3 | $375K | Buy |
16,919
+306
| +2% | +$6.78K | ﹤0.01% | 2692 |
|
|
2014
Q2 | $462K | Buy |
+16,613
| New | +$462K | ﹤0.01% | 2654 |
|